Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000043

CEO bought 96,000 shares at an average $0.01 ($1,186)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-16 Purchase : show line 1 in the form +5,000 $0.01 $71 24,767,797 D
2019-07-17 Purchase : show line 2 in the form +2,000 $0.01 $28 24,769,797 D
2019-07-17 Purchase : show line 3 in the form +5,000 $0.01 $69 24,774,797 D
2019-07-17 Purchase : show line 4 in the form +10,000 $0.01 $139 24,784,797 D
2019-07-17 Purchase : show line 5 in the form +10,000 $0.01 $140 24,794,797 D
2019-07-17 Purchase : show line 6 in the form +1,000 $0.01 $14 24,795,797 D
2019-07-18 Purchase : show line 7 in the form +10,000 $0.01 $111 24,805,797 D
2019-07-18 Purchase : show line 8 in the form +10,000 $0.01 $111 24,815,797 D
Open-market purchases · 96,000 sh · avg $0.01 · $1,186
Loading xslF345X03/primary_doc.xml…